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Department of Geriatric Medicine, University of Manchester, Barnes Hospital, Manchester, U.K. 
Bronchial challenge with methacholine or histamine is associated with a reduction in arterial oxygen tension, 
which can be appreciable. In this study, oxygen saturation was monitored during methacholine challenge in 
subjects with and without respiratory disease, over a wide age range, in order to identify factors predicting a 
large fall in saturation during the challenge. 
Two hundred and twenty subjects aged 2486 years were included, comprising 15 healthy adult volunteers, 
and 205 adults from a random sample of the local adult population taking part in a survey of bronchial 
responsiveness. Subjects with ischaemic heart disease or baseline FEV, 160% predicted were excluded. 
Methacholine challenge was performed by the Newcastle Dosimeter technique; oxygen saturation (,SaO,) was 
monitored using a pulse oximeter and finger probe. 
Of the 220 subjects, 27% were current smokers and 395% were ex-smokers; 26% reported asthma or 
bronchitis. Mean baseline FEV, was 100% predicted; mean baseline saturation was 97%. Mean fall in 
saturation was 3.2% (range O-17.5%). Multiple regression analysis revealed that fall in saturation during 
methacholine challenge is related to baseline FEV,, baseline SaO,, log of total methacholine dose inhaled, and 
fall in FEV, during challenge. Change in saturation was not related to subject age, smoking history, reported 
asthma or bronchitis, or the presence of respiratory symptoms. 
Methacholine challenge produces a significant fall in oxygen saturation, but this is not greater in subjects 
who are old or have low baseline saturation. 
Introduction 
Bronchial challenge with methacholine or hista- 
mine is widely used in research and clinical practice 
(1). Monitoring of arterial oxygen partial pressure 
either directly or indirectly, using a transcutaneous 
electrode or pulse oximeter, has shown that subjects 
undergoing such challenge experience varying 
degrees of hypoxia or desaturation (2-14). In most 
cases, this is small but, in a few subjects, it can be 
appreciable. Identification of those patients at risk 
of a significant fall in oxygenation or saturation 
during bronchial challenge would be useful. How- 
ever, most published studies have included small 
numbers of highly selected individuals, and have not 
identified factors predicting significant hypoxia or 
desaturation. 
In an attempt to identify such factors, the authors 
have monitored oxygen saturation during metha- 
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choline challenge in a large number of subjects over a 
wide age range, including smokers and non-smokers, 
and subjects with and without airways obstruction. 
Methods 
SUBJECTS 
Two hundred and twenty subjects (123 females) 
between the ages of 24 and 86 years completed the 
protocol. Fifteen were volunteers from the hospital 
staff (age 24433 years, mean age 26.1 years, six 
females); the remaining 205 subjects were a random 
sample of the local adult population, recruited for an 
epidemiological survey of bronchial responsiveness in 
the local community (age range 45-86 years, mean 
age 63.7 years, 117 females). Exclusion criteria for the 
epidemiological survey were as follows: cognitive 
impairment, immobility (inability to attend hospital 
for tests), non-Caucasian race (because of known 
inter-racial differences in bronchial responsiveness) 
(15), history of ischaemic heart disease, severe base- 
line airflow obstruction (FEV, ~60% predicted) (16), 
abnormal 12-lead ECG, current medication with 
oral steroids or anti-cholinergic drugs, and current 
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medication with oral or topical P-adrenergic antag- 
onists. The study was approved by the Central 
Manchester Health Authority Ethical Committee, 
and written informed consent was obtained from all 
subjects. 
Details of respiratory symptoms, history of 
obstructive airways disease (asthma or bronchitis), 
smoking history and current medications were 
obtained by postal questionnaire. Attendance for 
methacholine challenge was delayed until >6 weeks 
after a recent upper airways infection or exacerbation 
of wheezing. 
Methacholine challenge was performed by the 
Newcastle Dosimeter method (17,18). Subjects were 
asked to avoid caffeine-containing drinks for 12 h, 
and to omit bronchodilator medication for 12 h 
(inhaled preparations), 24 h (oral preparations) or 
48 h (long-acting preparations) prior to bronchial 
challenge. Doubling doses of nebulized methacholine 
were inhaled at 5-min intervals by the subject, seated 
and wearing a noseclip. FEV, (mean of three record- 
ings reproducible within 10%) was measured before 
each subsequent dose. End-points were a 20% 
decrease in FEV,, or administration of a maximum 
cumulative dose of 6.4 mg methacholine. Results 
were expressed as the methacholine dose producing a 
20% fall in FEV, (PD,,), and as the simplified slope 
of the FEV, dose-response curve (DRS) (19). 
Oxygen saturation (SaO,) was monitored using a 
finger oximeter (Biox 3700e, Ohmeda, Louisville, 
U.S.A.). The 95% confidence limits for background 
variability in SaO, in the authors’ laboratory 
(measured in young controls over 2 min) are * 2.7% 
(20). Since SaO, was observed to increase following 
the three FEV, manoeuvres, presumably secondary 
to a reduction in ventilation/perfusion mismatch 
resulting from repeated maximal inhalations, SaO, 
measurements were recorded immediately before 
each set of FEV, manoeuvres. 
STATISTICAL ANALYSIS 
Values for methacholine dose, PD,,, and DRS 
were transformed to logarithms prior to analysis 
to achieve a normal distribution. One subject had 
a slight increase in FEV, during methacholine 
challenge, producing a negative dose-response slope; 
to allow logarithmic conversion of this result, a 
constant of 0.43 was added to all dose-response slope 
values (21). 
Smoking history was expressed as number of pack 
years smoked, where 1 pack year=20 cigarettes 
day-’ for 1 yr. Comparison of subgroups was 
performed by grouped t-test. Multiple regression 
analysis was used to assess the influence of various 
parameters on oxygen saturation. Where inter- 
relationships were observed between independent 
variables in regression equation, interaction factors 
were included (21). 
In order to avoid the age and height bias 
associated with the expression of FEV, as percent 
of predicted values, baseline FEV, was expressed 
as standardized residuals (SR) (22). These were 
calculated using the equation SR= (recorded 
value-predicted value)/RSD, where RSD is the 
residual standard deviation about the regression 
equation used to calculate the predicted values (23). 
The prediction equations used for the calculation of 
standardized residuals were derived from urban white 
U.K. adults over a wide age range comparable to that 
of the current study (24). 
Increased bronchial responsiveness was defined as 
PD,,<400 pg methacholine (25). Chronic airflow 
obstruction was defined as FEV,/FVC% ~65% for 
subjects aged ~65 years; for those aged 2 65 years, a 
predicted value and lower limit of normal for FEV,/ 
FVC% was calculated as described by Enright et al. 
(26). In all cases, significance was defined at the 
5% level. 
Results 
Of the 220 subjects taking part, 60 (27%) were 
current smokers and 87 (39.5%) were ex-smokers. 
Fifty-seven subjects (26%) gave a history of obstruc- 
tive airways disease; 20 subjects reported asthma, 
28 subjects reported bronchitis, and nine subjects 
reported both diagnoses. Respiratory symptoms 
(cough, sputum, wheeze or breathlessness at rest/ 
walking on the level) were reported by 109 subjects. 
Mean baseline FEV, for the 220 subjects was 100% 
predicted (range 633177%) (16). Thirty-three subjects 
had airflow obstruction. One hundred and fifty-three 
subjects (69.5%) achieved a PD,,; 91 subjects had 
increased bronchial responsiveness. 
Mean baseline SaO, was 97.1% (range 91.5- 
99.5%). Baseline SaO, was higher in females than 
males [females 97.3% (SD 1.5), males 96.9% (SD 1.3), 
P=O.O05]. Mean fall in FEV, (VFEVJ during 
the methacholine challenge was 20.2% (range - 5.9- 
42.7%); mean fall in SaO, (VSaO,) was 3.2% 
(range - 4.0-17.5%). VSaO, was >lO% in only four 
subjects (Fig. 1). 
FACTORS AFECTING OXYGEN SATURATION 
Baseline SaO, 
There was no difference in baseline SaO, between 
subjects reporting asthma, bronchitis or no history of 
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Fall in SaO, (%) 
Fig. I Distribution of fall in oxygen saturation (SaO,) 
during methacholine challenge. 
obstructive airways disease. Baseline SaO, was lower 
in subjects with spirometric evidence of airflow 
obstruction [96.1% (SD 2.3)] than in those without 
airflow obstruction 197.1% (SD 1.2); P=O.O02]. Sub- 
jects reporting one or more respiratory symptoms 
had lower baseline SaO, [96.5% (SD l.S)] than 
asymptomatic subjects [97.2% (SD 1.2); P=O.OOOS]. 
Multiple regression analysis with baseline SaO, as 
the dependent variable showed an independent posi- 
tive relationship with FEV, (standardized residuals), 
and independent negative relationships with age, and 
with pack years smoked (Table 1). Baseline SaO, was 
also independently associated with sex (SaO, higher 
in women). Interaction factors for the relationships 
between age and pack years, and sex and pack years, 
did not alter the results. However, an interaction 
factor for the relationship between FEV, and pack 
years was strongly associated with baseline SaO, 
(B=0.02, SE=@59, P<O.OOOl), removing the indepen- 
dent relationships of baseline SaO, with FEV, and 
pack years. The square of the coefficient of multiple 
regression (R2) was 0.3 1. 
Fall in SaO, 
Fall in SaO, was similar in subjects reporting 
asthma, bronchitis and no history of obstructive 
airways disease. There was no difference in the 
Table I Factors associated with baseline oxygen 
saturation: multiple regression analysis 
coefficient SE P value 
FEV, 
(standardized residuals) 




- 0.03 0.008 0~0003 
- 0.01 0.004 0.003 
- 0.42 0.19 0.03 
No relationship was found between baseline saturation 
and bronchial responsiveness (log dose-response curve), 
haemoglobin, reported asthma or bronchitis, or respiratory 
symptoms R*=0.31. 
Table 2 Factors associated with change in oxygen 
saturation during methacholine challenge: multiple 
regression analysis 
Coefficient SE P value 
Fall in FEV, (%) 




0.11 0.03 <0~0001 
0.95 0.21 <0~0001 
0.35 0.14 0.01 
- 0.41 0.2 0.04 
No relationship was found between fall in saturation and 
bronchial responsiveness (log dose-response curve), age, 
sex, pack years, reported asthma/bronchitis, or respiratory 
symptoms R2=0.18. 
fall in SaO, between subjects with and without air- 
flow obstruction, or between symptomatic and 
asymptomatic subjects. 
Multiple regression analysis showed VSaO, to be 
positively associated with baseline saturation, fall in 
FEV, during challenge (as % of baseline), and the log 
of the methacholine dose given; VSaO, was nega- 
tively associated with baseline FEV, (standardized 
residuals) (Table 2). When interaction factors were 
added to the regression for the relationships between 
fall in FEV, and log methacholine dose (B= - 0.04, 
SE=O.O07, P=O.OOS), and between baseline satura- 
tion and baseline FEV, (B= - 0.0004, SE=@002, 
P=O.O4), these replaced the individual variables as 
significant determinants of VSaO,. RZ was 0.16. 
There was no relationship between VSaO, and 
age, sex, pack years, bronchial responsiveness or 
haemoglobin. 
Discussion 
Previous smaller studies have shown a relationship 
between the change in oxygenation during bronchial 
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challenge and either the change in FEV, (2-4) the 
dose of challenge agent inhaled (5), the pre-challenge 
level of oxygenation (6), or none of these parameters 
(7). The current study has shown that the change in 
saturation is related to all of the above parameters, as 
well as the baseline FEV,. However, the low coeffi- 
cient of multiple regression indicates that only 18% of 
the variation in SaO, is attributable to the measured 
parameters, and so other unidentified factors must be 
involved. 
The present study population included subjects over 
a wide age range. Most other studies have included 
only children or small numbers of young adults. The 
only other study to have included elderly subjects 
(age range 19-77 years) had a mean age of 46 years, 
suggesting that few older subjects were included (7). 
No other study of oxygen saturation during 
bronchial challenge has included adults with chronic 
airflow obstruction. Although subjects with FEV, 
~60% predicted were excluded, 15% of the popula- 
tion had spirometric evidence of chronic air-how 
obstruction. Asthma and chronic bronchitis might be 
expected to have different effects on oxygen satura- 
tion, but no difference was found during metha- 
choline challenge between subjects reporting these 
diagnoses. However, subtle differences might be 
detected using a more sensitive technique for the 
measurement of oxygenation. 
Direct measurement of partial pressure of oxygen 
(PaO,) in arterial blood samples is inconvenient 
and uncomfortable for patients. The use of a trans- 
cutaneous electrode to measure partial pressure of 
oxygen (PtcO,) gives similar results during bronchial 
challenge (9); measurement of oxygen saturation by 
pulse oximeter gave comparable results in one study 
(lo), but not another (11). Because of the sigmoid 
oxygen saturation curve, large changes in SaO, only 
occur once the PaO, has fallen below 60 mmHg (27); 
thus monitoring of saturation is relatively insensitive 
in well-oxygenated subjects. Despite this, all but one 
study using SaO, during bronchial challenge showed 
a statistically significant mean fall in SaO, of around 
3%, which is consistent with the results of the present 
study (9,7,11-13). 
The fact that V SaO, during bronchial challenge is 
not related to V FEV, alone but also to methacholine 
dose suggests that methacholine may be altering 
SaO, both indirectly, via reduction in airways 
calibre, and also directly, by some other mechanism. 
Such mechanisms could include alteration of 
ventilation-perfusion distributions, as have been 
recorded during bronchial challenge (6). 
The authors had hoped to identify baseline factors 
which could be used to identify subjects at risk of 
hypoxia during methacholine challenge. However, 
although VSaO, is associated with baseline FEV, 
(confirming the expectation that subjects with 
chronic airflow obstruction may become hypoxic 
during methacholine challenge), there is also a posi- 
tive association with baseline SaO,. This unexpected 
relationship has been noted previously in a study of 
PaO, during methacholine challenge in asthmatic 
patients (6) and may represent a form of regression 
to the mean. 
Elderly subjects in the study population, despite 
having lower baseline FEV, and oxygen saturation, 
were not at increased risk of desaturation during 
methacholine challenge. This reinforces the assertion 
that bronchial challenge with methacholine is a safe 
and useful technique in this age group (17). A fall in 
SaO, with increasing age has been reported pre- 
viously (28), but was not demonstrated in adults aged 
>65 years with chronic bronchitis (29). 
In summary, in the majority of cases, the fall in 
oxygen saturation occurring during methacholine 
challenge is small; older patients and those with low 
baseline SaO, are not at increased risk of desatura- 
tion. However, it is not clear whether these results 
can be extrapolated to subjects excluded from this 
study, for example those with baseline FEV, ~60% 
predicted or with ischaemic heart disease. 
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